0001062993-15-002351.txt : 20150504
0001062993-15-002351.hdr.sgml : 20150504
20150504170157
ACCESSION NUMBER: 0001062993-15-002351
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141202
FILED AS OF DATE: 20150504
DATE AS OF CHANGE: 20150504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wegman Toby
CENTRAL INDEX KEY: 0001405128
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 15829293
MAIL ADDRESS:
STREET 1: 4092 BOCAIRE BLVD.
CITY: BOCA RATON
STATE: FL
ZIP: 33487
4/A
1
form4a.xml
AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4/A
2014-12-02
2014-12-04
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001405128
Wegman Toby
C/O BIOSPECIFICS TECHNOLOGIES CORP.
35 WILBUR STREET
LYNBROOK
NY
11563
1
0
0
0
Coomon Stock, $0.001 par value
2014-12-02
4
S
0
2950
39.39
D
0
D
The purpose of this Form 4/A is solely to correct the amount of securities beneficially owned by the reporting person and does not represent any acquisition or disposition of shares by the reporting person.
/s/ Toby Wegman by Carl A. Valenstein, attorney in fact
2015-05-04